A syndrome of severe growth failure with facial features that resembled growth hormone (GH) deficiency, but with high levels of GH in the serum, was described initially in 1966 by Laron et al. ' Affected subjects were Oriental Jews from largely consanguineous unions.2 Administration of exogenous GH failed to stimulate somatomedin (IGF-I) production,3 indicating a defect in cellular response to GH which was eventually proven to be the result of failure of the GH receptor.45 Some 180 patients have been described with growth hormone receptor deficiency (GHRD)/Laron syndrome, of whom all but a few are of Mediterranean or Middle Eastern origin, and nearly 70% are semitic. These numbers include 65 patients from a small region (120 km diameter) of southern Ecuador who are inbred white Spaniards with names that indicate that they are conversos, Jews who became Catholics during the Inquisition. 6 Affected persons have been described as having "acromicria", defined as small hands, feet, and faces. Craniofacial disproportion was described and quantified as an abnormal difference between the biparietal and bicondylar diameter compared to normal. 7 We questioned whether the face might appear small because it is proportionate to body size while the more normal head appears macrocephalic (fig 1) .8 This craniofacial disproportion is particularly striking in young children, who often also have the "setting sun sign", the appearance of sclera above the iris. These findings may be so striking that hydrocephalus is suspected.
There Facial morphometric comparisons between patients with GHRD (group 3, n = 49), unaffected relatives (group 2, n = 69), and unrelated persons (group 1, n = 16) deviation from normal in stature than for head circumference. Head circumference SDS for height age, however, was normal for both children (+0-5 (SD 1-3)) and adults (-0-4 (SD 1 4) We initially compared morphometric data between affected subjects with GHRD (group 3) and unaffected first or second degree relatives (group 2). It was particularly attractive initially to compare these two groups as they had nearly identical age distributions, the same 2:1 female predominance (as previously reported), and the ability to use relatives to correct for any familial facial differences.
When the two groups were compared, numerous strongly significant differences were noted (table) . All of these differences have in common a decrease in the absolute vertical dimension of the entire face, most impressively in the midface region. When patients in group 3 were compared to those in group 1 (unrelated subjects with short stature from other causes) the findings were similar to comparisons with group 2 (table) . Again, the findings were suggestive of a decreased vertical dimension of the entire face in patients with GHRD.
Comparison of unaffected relatives (group 2) to unrelated controls with other causes of short stature (group 1) showed only two significant differences. Group 1 as compared to group 2 had an increase in the Y coordinate of triangle 14-16-17 (p=O00001) and a decrease in the Y of triangle 14-19-18 (p=0-001). Neither of these findings relates to the changes noted in the patients with GHRD, which supports the notion that the findings above are clinically significant.
Discussion
These data (table) show a striking decrease in vertical facial growth in patients with GHRD. When patients with GHRD (group 3) are compared to their unaffected relatives (group 2), all measures of vertical facial dimensions, with the exception of triangle 6-7-24 ( fig 2) were significantly reduced. The measurements for this triangle bordered on statistical significance (p = 0 07) but there was a relatively large variance in their parameters which negated significance. It is not certain why the dimensions of this particular triangle should show such a large degree of variance. One possible explanation could be that the reference line (6-7), a measure of inner canthal distance, simply has a naturally occurring large degree of variance within this kinship. Regardless, the clear pattern from these data is that vertical facial growth is markedly foreshortened in patients with GHRD.
When we compared patients with GHRD to unrelated persons (group 1) with short stature on the basis of other problems (mainly GH deficiency) we found similar results (table). It is interesting that triangle 6-7-24 was significantly different in this comparison, again suggesting some inherent degree of variability in the kinship studied. Five measures (triangles 9-10-26, 27-28-25, 27-28-12, 5-8-25 , and 5-8-24), which were significantly different when group 3 (patients with GHRD) was compared to group 2 (unaffected relatives), were not different when groups 3 and 1 were compared. This may be in part because of the fact that groups 2 and 3 have similar mean ages and a 2:1 female to male ratio, while group 1 had a smaller mean age and a 1:2 male to female ratio. Comparison of group 2 to group 1 showed no differences in vertical facial dimensions, however. As mentioned previously, group 1 consisted largely of patients with GH deficiency; all patients in this group had a height of less than 2 SDS from the age appropriate mean, whereas group 2 all had normal stature. Thus, the difference seen in our patients with GHRD cannot be explained on the basis that they simply had a shorter total body height.
We have previously noted that head circumference SDS for chronological age was much less abnormal than height SDS in persons with GHRD in Ecuador. This discrepancy was thought to contribute to the appearance of a large cranium and small facies. Cranial circumference is, however, normal for height age in these patients, indicating that 
